GSK3B and obesity disorder: Similarly, we found GSK-3β upregulation to cause delayed GE by reducing levels/activity of gastric PI3K/Akt/Nrf2, Phase II enzymes, and BH4-nNOSα in an obesity-induced diabetes mouse model [19].